A World Cup Full of Firsts
The World Cup is underway, and it’s already one for the history books. It’s expected
Full
Bolt Biotherapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
– Upsized IPO in February 2021 raised $264.5 million in gross proceeds plus Series C
BiomX Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
NESS ZIONA, Israel–(BUSINESS WIRE)–Mar 31, 2021– BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”),
Frequency Therapeutics Supplies Enterprise Updates and Reports Fourth Quarter and Full Year 2020 Fiscal Results
WOBURN, Mass.–(Enterprise WIRE)–Mar 29, 2021– Frequency Therapeutics, Inc. (Nasdaq: FREQ), a medical-stage biotechnology organization concentrated
I-Mab Reports Financial Results for Full Year of 2020 and Provides Business Updates
18 significant clinical milestones achieved since the Company’s IPO in January 2020, with multiple important
Evolus Reports Fourth Quarter and Full Year 2020 Results and Provides Business Update
Q4 2020 Net Revenue $20.6 Million, Highest Net Revenue Quarter Since Launch of Jeuveau® Pro
Celyad Oncology Reports Full Year 2020 Financial Results and Recent Business Highlights
No safety concerns or evidence of Graft-versus-Host disease reported from first dose cohort of Phase
Aligos Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
– Advanced ALG-010133 and ALG-000184 into the clinic – both expected to generate safety and
Newtek Business Services Corp. Reports Full Year 2020 Financial Results
BOCA RATON, Fla., March 22, 2021 (GLOBE NEWSWIRE) — Newtek Business Services Corp. (“Newtek” or
AgweekTV Full Show: New EPA administrator, acreage battle, livestock business, meat processing
COMING UP ON AGWEEK TV THE NEW EPA ADMINISTRATOR AND U.S. TRADE REP ARE CONFIRMED,
Legend Biotech Reports Fourth Quarter and Full Year 2020 Financial Results and Business Update
Legend received approximately $659.8 million in gross proceeds through share capital increases during 2020, including
Ocugen Provides Business Update and Full Year 2020 Financial Results
Conference Call and Webcast Today at 8:30 a.m. ET COVID-19 vaccine candidate, COVAXIN™, demonstrates efficacy
PLAYSTUDIOS, Inc. Announces Preliminary Fourth Quarter and Full Year 2020 Results Along With Recent Business Highlights
– Fourth Quarter Revenue of $64.0 million and Full Year 2020 Revenue of $269.9 million,
Adicet Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Received IND clearance and initiated first-in-human Phase 1 clinical trial for lead asset, ADI-001, an
Eloxx Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial and Operating Results and Provides Business Update
We expect to report top line data from our Phase 2 cystic fibrosis clinical trials
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing
Health: Aquestive Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update Nasdaq:AQST
News Highlights Libervant™ (diazepam) Buccal Film New Drug Application (NDA) resubmission expected end of second
Aquestive Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Libervant™ (diazepam) Buccal Film New Drug Application (NDA) resubmission expected end of second quarter 2021